US court finds Teva's Copaxone patent invalid again: Natco Pharma

Natco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Copaxone as invalid.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news